"hepatocellular carcinoma" trang 9 - tải miễn phí từ tailieunhanh
CDCA5 overexpression is an Indicator of poor prognosis in patients with hepatocellular carcinoma (HCC)

CDCA5 overexpression is an Indicator of poor prognosis in patients with hepatocellular carcinoma (HCC)
10    71    1
SKA1 overexpression is associated with poor prognosis in hepatocellular carcinoma

SKA1 overexpression is associated with poor prognosis in hepatocellular carcinoma
8    66    1
Safety and efficacy of cytotoxic chemotherapy in hepatocellular carcinoma after first-line treatment with sorafenib

Safety and efficacy of cytotoxic chemotherapy in hepatocellular carcinoma after first-line treatment with sorafenib
7    30    1
Dietary intake of genistein suppresses hepatocellular carcinoma through AMPK-mediated apoptosis and anti-inflammation

Dietary intake of genistein suppresses hepatocellular carcinoma through AMPK-mediated apoptosis and anti-inflammation
12    36    1
Is there a sex difference in postoperative prognosis of hepatocellular carcinoma?

Is there a sex difference in postoperative prognosis of hepatocellular carcinoma?
13    39    1
Comparing stereotactic ablative radiotherapy (SABR) versus re-trans-catheter arterial chemoembolization (re-TACE) for hepatocellular carcinoma patients who had incomplete response after initial TACE (TASABR): A randomized controlled trial

Comparing stereotactic ablative radiotherapy (SABR) versus re-trans-catheter arterial chemoembolization (re-TACE) for hepatocellular carcinoma patients who had incomplete response after initial TACE (TASABR): A randomized controlled trial
11    33    5
First-in-class immune-modulating small molecule Icaritin in advanced hepatocellular carcinoma: Preliminary results of safety, durable survival and immune biomarkers

First-in-class immune-modulating small molecule Icaritin in advanced hepatocellular carcinoma: Preliminary results of safety, durable survival and immune biomarkers
11    37    2
Genome-wide copy number alteration and VEGFA amplification of circulating cell-free DNA as a biomarker in advanced hepatocellular carcinoma patients treated with Sorafenib

Genome-wide copy number alteration and VEGFA amplification of circulating cell-free DNA as a biomarker in advanced hepatocellular carcinoma patients treated with Sorafenib
13    31    1
Efficacy of bevacizumab combined with erlotinib for advanced hepatocellular carcinoma: A single-arm meta-analysis based on prospective studies

Efficacy of bevacizumab combined with erlotinib for advanced hepatocellular carcinoma: A single-arm meta-analysis based on prospective studies
13    67    1
Feasibility of dynamic risk assessment for patients with repeated trans-arterial chemoembolization for hepatocellular carcinoma

Feasibility of dynamic risk assessment for patients with repeated trans-arterial chemoembolization for hepatocellular carcinoma
10    31    1
Late presentation of hepatitis B among patients with newly diagnosed hepatocellular carcinoma: A national cohort study

Late presentation of hepatitis B among patients with newly diagnosed hepatocellular carcinoma: A national cohort study
8    37    1
Long-term outcomes of the 2-week schedule of hypofractionated radiotherapy for recurrent hepatocellular carcinoma

Long-term outcomes of the 2-week schedule of hypofractionated radiotherapy for recurrent hepatocellular carcinoma
8    38    1
Synchronous cancers of gallbladder carcinoma and combined hepatocellular cholangiocarcinoma: An unusual case and literature review

Synchronous cancers of gallbladder carcinoma and combined hepatocellular cholangiocarcinoma: An unusual case and literature review
7    37    1
Does fibrosis have an impact on survival of patients with hepatocellular carcinoma: Evidence from the SEER database?

Does fibrosis have an impact on survival of patients with hepatocellular carcinoma: Evidence from the SEER database?
9    79    1
Preoperative diagnosis and prediction of hepatocellular carcinoma: Radiomics analysis based on multi-modal ultrasound images

Preoperative diagnosis and prediction of hepatocellular carcinoma: Radiomics analysis based on multi-modal ultrasound images
11    54    1
The predictive powers of plasma trefoil factor 3 or its related micro RNAs for patients with hepatocellular carcinoma

The predictive powers of plasma trefoil factor 3 or its related micro RNAs for patients with hepatocellular carcinoma
6    38    1
Comparison of the efficacy and safety of transarterial chemoembolization with and without Apatinib for the treatment of BCLC stage C hepatocellular carcinoma

Comparison of the efficacy and safety of transarterial chemoembolization with and without Apatinib for the treatment of BCLC stage C hepatocellular carcinoma
8    77    1
Extracellular matrix collagen I promotes the tumor progression of residual hepatocellular carcinoma after heat treatment

Extracellular matrix collagen I promotes the tumor progression of residual hepatocellular carcinoma after heat treatment
11    62    1
Noncontrast magnetic resonance imaging versus ultrasonography for hepatocellular carcinoma surveillance (MIRACLE-HCC): Study protocol for a prospective randomized trial

Noncontrast magnetic resonance imaging versus ultrasonography for hepatocellular carcinoma surveillance (MIRACLE-HCC): Study protocol for a prospective randomized trial
8    46    1
Oncogenic potential of N-terminal deletion and S45Y mutant β-catenin in promoting hepatocellular carcinoma development in mice

Oncogenic potential of N-terminal deletion and S45Y mutant β-catenin in promoting hepatocellular carcinoma development in mice
11    73    1